2025 Researcher Appreciation Day | Emory School of Medicine

Department of Surgery Olamide Alabi

Dr. Olamide Alabi is committed to advancing health equity, particularly in peripheral artery and aortic diseases, through evidence-based interventions and implementation science. Her work also enhances surgical education by refining curricula and promoting simulation-based training. She is making a profound impact on healthcare delivery in the greater Atlanta area, especially for Veterans, by improving outcomes and overall population health.

Read more about this researcher’s publications and impactful work.

Department of Human Genetics Jimena Andersen

Dr. Jimena Andersen investigates the development and function of the spinal cord and motor cortex to better understand neurodevelopmental and neurodegenerative diseases. She is a global leader in the use of assembloids - mini-organ systems that model brain-spinal cord interactions - to study ALS. Her pioneering work with patient-derived stem cells is transforming how we approach disease mechanisms and therapeutic development.

Department of Hematology and Medical Oncology Martha Arellano

Dr. Martha Arellano leads groundbreaking clinical research in acute leukemias, focusing on therapies that target the scaffolding protein menin. Her work has catalyzed practice-changing advances in the treatment of acute myeloid leukemia (AML), one of the most aggressive blood cancers. Through her innovative investigations, she is reshaping therapeutic strategies and offering new hope to patients.

Read more about this researcher’s publications and impactful work.

Department of Medicine Alexandra Arges

Dr. Alexandra Arges enhances inpatient care by studying length of stay as a marker for quality and implementing evidence-based practices like sickle cell order sets. She also educates internal medicine physicians on best practices for managing cirrhosis. As a hospitalist, her research drives system-level improvements that elevate care standards and patient outcomes in tertiary care settings.

Department of Medicine Sara Auld

Dr. Sara Auld investigates tuberculosis (TB) and HIV coinfection, with a focus on the immune response and post-TB lung disease (PTLD). She leads the INFIN-TB study to uncover early-stage factors that worsen PTLD, a major global cause of chronic lung disease. Her goal is to develop host-directed therapies that reduce PTLD severity, improving long-term outcomes for TB patients worldwide.

Read more about this researcher’s publications and impactful work.

Department of Medicine Prabhava Bagla

Dr. Prabhava Bagla’s research centers on quality improvement in hospital care. His work on nursing communication preferences during physician rounds and co-management of hip fracture patients is shaping better care coordination at Grady Memorial Hospital. His findings offer scalable solutions for enhancing inpatient care across institutions.

Department of Medicine Dylan Baker

Dr. Dylan Baker leads research on Long-Acting PrEP (LAP) implementation to prevent HIV in underserved communities. As Associate Medical Director of the Grady PrEP Clinic, he launched one of the Southeast’s largest LAP programs. His work demonstrates high adherence and low discontinuation, offering a replicable model for HIV prevention in resource-limited settings.

Read more about this researcher’s publications and impactful work.

Department of Anesthesiology Vipin Bansal

Dr. Vipin Bansal is pioneering non-opioid, non-invasive pain management for sickle cell disease using transauricular vagal nerve stimulation. His research addresses the challenges of complex pain, aiming to reduce hospital stays and improve quality of life for patients with chronic pain.

Read more about this researcher’s publications and impactful work.

Department of Hematology and Medical Oncology Benjamin Barwick

Dr. Benjamin Barwick is a rising leader in multiple myeloma research, using computational and laboratory approaches to uncover genomic and epigenetic drivers of disease. His work is shaping targeted therapies and has earned recognition in top journals and expert commentaries.

Read more about this researcher’s publications and impactful work.

Department of Medicine Arpita Basu

Dr. Arpita Basu is improving kidney transplant outcomes by tailoring immunosuppression protocols for HIV-positive patients. Her collaborative work with infectious disease experts at Emory has led to promising results using Belatacept, enhancing both patient and graft longevity.

Read more about this researcher’s publications and impactful work.

Department of Medicine Pradeep Bathina

Dr. Pradeep Bathina leverages large datasets to optimize lab testing and uncover widespread micronutrient deficiencies. His research promotes cost-effective care and raises awareness of nutritional gaps, driving improvements in patient health and healthcare resource use.

Department of Psychiatry and Behavioral Sciences Mandakh Bekhbat

Dr. Mandakh Bekhbat applies bioinformatics and translational research to explore immune and metabolic pathways in depression and medical illness. Her work spans animal models to clinical studies, positioning her as a key contributor to understanding inflammation-related psychiatric symptoms.

Department of Medicine Siva Bhavani

Dr. Siva Bhavani is a Pulmonary and Critical Care physician and data scientist leading the PRECISE trial to define sepsis subphenotypes using machine learning on routine bedside vital signs. His goal is to enable precision medicine for septic and ICU patients. Supported by NIH and AIM-HI grants, he identified a subgroup of older septic patients who benefit more from balanced crystalloids than normal saline, advancing individualized care in critical settings.

Read more about this researcher’s publications and impactful work.

Department of Surgery Luke Brewster

Dr. Luke Brewster investigates the biomechanical mechanisms underlying arteriosclerosis and peripheral vascular disease, focusing on how stiffened arteries disrupt blood flow dynamics. His laboratory develops therapeutics to restore vascular hysteresis using in vivo and ex vivo models. By advancing regenerative strategies for ischemic tissue, he aims to improve vascular function and patient outcomes, contributing to innovative treatments for chronic circulatory disorders.

Department of Medicine Hui Cai

Dr. Hui Cai’s research investigates WNK kinase signaling and its regulation of renal BK channels and NCC, with implications for blood pressure and potassium balance. His recent work explores BK channel roles in renal fibrosis and cardiorenal syndrome, offering new therapeutic insights for chronic kidney disease. Supported by VA, AHA, and NIH grants, his discoveries are shaping the future of CKD and hypertension management.

Department of Pediatrics Ann Chahroudi

Dr. Ann Chahroudi’s research focuses on HIV persistence and Zika virus neurodevelopmental effects using nonhuman primate models. Her NIH-funded studies advance HIV cure strategies and illuminate Zika’s impact on early brain development. She also plays a key role in mentoring pediatric physician-scientists, contributing to both scientific progress and workforce development.

Department of Medicine Rosette J. Chakkalakal

Dr. Rosette J. Chakkalakal leads translational research aimed at reducing type 2 diabetes in high-risk populations. In 2024 alone, she directed four federally funded projects totaling over $5 million. With more than $10 million in career grant support and 31 peer-reviewed publications, her work - especially through Emory collaborations - is making a national impact on diabetes care and prevention.

Department of Pharmacology and Chemical Biology Jae Won Chang

Dr. Jae Won Chang is a multidisciplinary investigator advancing disease biology and therapeutic discovery through chemical innovation. His development of novel chemical probes and a photoacoustic tumor imaging tool enables early detection and targeted treatment of cancer and neurodegenerative diseases. His work bridges chemistry and medicine to transform diagnostic and therapeutic strategies.

Read more about this researcher’s publications and impactful work.

Department of Dermatology Sarah Chisolm

Dr. Sarah Chisolm is Director of the Center for the Study of Itch and the Clinical Trials Unit in the Department of Dermatology. She has spearheaded numerous clinical trials that bring cutting-edge therapeutics to underserved patients with itch and dermatitis. Through strategic industry partnerships, she has transformed the department’s research landscape and accelerated drug development in dermatologic care.

Department of Pediatrics Satheesh Chonat

Dr. Satheesh Chonat’s research centers on complement activation in hematologic diseases, particularly sickle cell disease (SCD). He developed a mouse model to study complement’s role in acute chest syndrome and leads clinical trials on complement inhibitors. His landmark findings have reshaped understanding of hemolysis in SCD and opened new therapeutic pathways.

Read more about this researcher’s publications and impactful work.

Department of Medicine Lauren Collins

Dr. Lauren Collins is an early career investigator advancing research on HIV, long-acting treatments, and age-related comorbidities. Her work highlights sex and gender differences in disease progression, especially among women with HIV. She is a national leader in implementing long-acting HIV therapies, with widely published findings and broad community engagement.

Read more about this researcher’s publications and impactful work.

Department of Psychiatry and Behavioral Sciences Vincent Costa

Dr. Vincent Costa integrates reinforcement learning and systems neuroscience to study decision-making in rhesus macaques and humans. His research reveals how motivational neural circuits influence behavior and mental health, offering new diagnostic and therapeutic strategies. He is widely regarded as one of the most promising behavioral neuroscientists of his generation.

Read more about this researcher’s publications and impactful work.

Department of Rehabilitation Medicine Zachary Danziger

Dr. Zachary Danziger investigates how the nervous system controls the body through modeling, simulation, and brain-computer interfaces. His work enhances robotic interaction for people with severe disabilities and explores spinal cord injury models to improve urinary control. His research bridges neuroscience and technology to improve quality of life.

Read more about this researcher’s publications and impactful work.

Department of Radiation Oncology Xingming Deng

Dr. Xingming Deng studies cell death, DNA replication stress, and genomic instability to develop novel anti-cancer therapies. His work targets apoptosis and DNA repair pathways, offering new strategies to overcome treatment resistance. He is a leading figure in cancer biology, with discoveries that drive innovation in oncology.

Read more about this researcher’s publications and impactful work.

Department of Orthopaedics Hicham Drissi

Dr. Hicham Drissi has led a transformative musculoskeletal research program for over 25 years, advancing skeletal regeneration, osteoarthritis, and vertebral disc degeneration. His lab made seminal discoveries in bone remodeling, including the role of Runx1 and a modified form of Wnt5a that promotes bone formation. With a top-tier h-index and millions in grant funding, Dr. Drissi’s work continues to shape the future of bone health and inspire the next generation of scientists.

Department of Pharmacology and Chemical Biology Yuhong Du

Dr. Yuhong Du is a global leader in miniaturized assay development and high-throughput screening for drug discovery. Her innovative work includes creating 3D cancer organoids in 1536-well plate formats, revolutionizing anticancer drug screening. As co-director of the Emory Chemical Biology Discovery Center, she empowers researchers across disciplines to identify chemical probes and therapeutic candidates with precision and speed.

Read more about this researcher’s publications and impactful work.

Department of Medicine Matthew Dudgeon

Dr. Matthew Dudgeon brings a multidisciplinary lens to health equity research, combining expertise in medical anthropology, epidemiology, and infectious disease. His work spans maternal mortality toolkits, vaccine exemplar studies, and ultrasound training innovations. Currently, he investigates socioeconomic and metabolomic factors in virologic failure in South Africa, continuing his mission to achieve global health equity.

Read more about this researcher’s publications and impactful work.

Department of Hematology and Medical Oncology Fuad El Rassi

Dr. Fuad El Rassi has dedicated over a decade to advancing sickle cell therapeutics, leading landmark clinical trials that bring novel treatments to underserved populations. His efforts have positioned the Grady Sickle Cell Center at the forefront of phase I trials, expanding the therapeutic arsenal and improving outcomes for patients with sickle cell anemia.

Read more about this researcher’s publications and impactful work.

Department of Psychiatry and Behavioral Sciences Donovan Ellis

Dr. Donovan Ellis integrates digital innovation and cultural responsiveness into mental health care, developing AI-augmented therapies and digital navigator roles to enhance access and engagement. His population health approach ensures that cutting-edge treatments for anxiety and OCD are scalable, equitable, and effective across diverse clinical settings.

Read more about this researcher’s publications and impactful work.

Department of Psychiatry and Behavioral Sciences Negar Fani

Dr. Negar Fani is a leading clinician-scientist in trauma research, known for her neuroimaging studies linking white matter integrity and genetic polymorphisms to PTSD. She has broken ground in attentional bias research among diverse populations and is now developing vibroacoustic tools to address interoceptive deficits in trauma-exposed individuals, advancing both science and care.

Read more about this researcher’s publications and impactful work.

Department of Medicine Shaheen Fatima

Dr. Shaheen Fatima focuses on improving patient safety and care coordination in hospital medicine. Her research targets iatrogenic anemia and discharge barriers, with initiatives that optimize evidence-based care for sickle cell patients. She also serves nationally as Secretary of the Society of Hospital Medicine’s Research Special Interest Group, amplifying her impact beyond the institution.

Department of Dermatology Ron Feldman

Dr. Ron Feldman is a renowned expert in autoimmune blistering diseases, serving as Vice Chair of Research in Dermatology. His translational research has enhanced therapeutics and quality of life for patients with pemphigus and pemphigoid. Through his leadership in clinical trials and mentorship, Dr. Feldman continues to elevate dermatologic care and research.

Department of Psychiatry and Behavioral Sciences Jennifer Felger

Dr. Jennifer Felger leads a pioneering research program that integrates basic and clinical neuroimaging to uncover how inflammation affects neurotransmitters and brain circuits in psychiatric illness. Her focus on dopamine has expanded the work of Emory’s psychoneuroimmunology group, revealing how inflammation disrupts motivational neurocircuitry. Her discovery that levodopa can reverse inflammation-induced anhedonia is considered paradigm-shifting, paving the way for personalized antidepressant therapies for patients with elevated inflammation.

Read more about this researcher’s publications and impactful work.

Department of Pediatrics Jairo Fonseca

Dr. Jairo Fonseca is advancing the search for an HIV cure through innovative in-vitro models and pre-clinical rhesus studies. His work centers on pediatric patients living with HIV—a population often overlooked in drug development. By focusing on this vulnerable group, Dr. Fonseca is helping to shape a more inclusive and effective future for HIV therapeutics.

Read more about this researcher’s publications and impactful work.

Department of Surgery Mandy Ford

Dr. Mandy Ford, Professor of Surgery and Scientific Director of the Emory Transplant Center, investigates T cell responses in transplantation, with a focus on costimulatory and coinhibitory pathways. Her research has led to the development of third-generation costimulation blockers, offering safer immunosuppressive strategies. She also explores connections between transplant immunology and sepsis, and is expanding her work into cancer immunotherapy, driving innovation across multiple disciplines.

Read more about this researcher’s publications and impactful work.

Department of Pediatrics Michael Fundora

Dr. Michael Fundora is dedicated to improving surgical outcomes in children with congenital heart disease. His collaborative research explores biopsychosocial risk factors such as growth and neurodevelopment delays, and he co-leads projects investigating gut health and multi-omics mechanisms including the microbiome and inflammation. His commitment to team science and mentorship sets a powerful example for clinician-scientists.

Read more about this researcher’s publications and impactful work.

Department of Medicine Matthew Gardner

Dr. Matthew Gardner is a leading researcher in gene therapy for Duchenne Muscular Dystrophy (DMD), known for bridging bench science with bedside application. His work on immune responses to adeno-associated virus (AAV) in both human and non-human primates is critical to advancing AAV-based therapies. His team’s profiling of AAV antibody seroprevalence in DMD patients across metro Atlanta lays essential groundwork for future clinical trials.

Department of Otolaryngology Amanda Gillespie

Dr. Amanda Gillespie is internationally recognized for her work in voice disorders and therapy. Her research focuses on improving the transition from therapy to everyday speech, using conversational methods to enhance outcomes. She is developing novel technologies to support patients with Parkinson’s disease and has earned two highly competitive R01 grants this year. Her work continues to redefine voice therapy and improve quality of life for patients worldwide.

Read more about this researcher’s publications and impactful work.

Department of Neurology Ezequiel Gleichgerrcht

Dr. Ezequiel Gleichgerrcht is transforming epilepsy care through precision medicine. His research integrates neuroimaging, intracranial electrophysiology, and machine learning to predict surgical outcomes in drug-resistant epilepsy. By identifying biomarkers that guide clinical decision-making, his work improves diagnosis, personalizes treatment, and reduces morbidity. Though early in his career, he is already recognized nationally for his revolutionary approach to medically intractable epilepsy.

Read more about this researcher’s publications and impactful work.

Department of Pathology and Laboratory Medicine Yesim Gokmen-Polar

Dr. Yesmin Polar has uncovered a novel mechanism of resistance to CDK4/6 inhibitors in ER+ breast cancer, identifying the role of GPNMB as a key driver. Her team validated this finding using genomic data from the PEARL trial and developed a magnetic screening nanoplatform to target GPNMB directly. Now focused on designing GPNMB-specific modulators, her work offers hope for reversing resistance and improving outcomes for patients with advanced breast cancer. With multiple federal grants and patents, she is leading a critical shift in breast cancer therapeutics.

Department of Psychiatry and Behavioral Sciences David Goldsmith

Dr. David Goldsmith investigates the role of inflammation in persistent negative symptoms of schizophrenia. His research has mapped a neural circuit from the basal ganglia to the insula involved in reward processing and is now testing infliximab, a TNF antagonist, as a potential treatment for patients with inflammatory pathology and motivational deficits. His work bridges psychoneuroimmunology and psychiatry, advancing immune-based therapeutics and offering new hope for a difficult-to-treat subgroup of patients.

Read more about this researcher’s publications and impactful work.

Department of Pediatrics Jocelyn Grunwell

Dr. Jocelyn Grunwell is a nationally recognized leader in pediatric critical care, whose research focuses on airway immune responses in children with acute respiratory distress syndrome (ARDS) and life-threatening asthma. As a senior member of the Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) network and principal investigator on two pediatric-focused RO1 grants—a distinction that is exceptionally rare in her field—she is advancing the understanding of immunophenotyping and patient-reported outcomes in pediatric ARDS. Her work fills a critical gap in the biology and phenotyping of pediatric respiratory illness and has direct impact across Georgia and the Southeast, where asthma prevalence remains high.

Department of Medicine Michael Hart

The Hart Lab investigates vascular cell biology to understand how changes in gene expression and metabolism contribute to systemic and pulmonary vascular disease. Dr. Michael Hart's work has shown that activating PPARγ with anti-diabetic medications can reduce pulmonary hypertension in animal models, and they are now testing this strategy in clinical trials. Recent discoveries about mitochondrial regulation offer new therapeutic targets. Their research is especially impactful for veterans, advancing treatment options for vascular disease in this population.

Department of Anesthesiology Rachel Hadler

Dr. Rachel Hadler studies the human experience of critical illness, with a focus on improving communication, shared decision-making, and access to care. Her research addresses providing palliative care to people in rural areas, aiming to enhance the quality and equity of critical care delivery. By centering the voices of patients and families, she is helping to reshape how care is provided during life’s most vulnerable moments.

Department of Medicine Peijian He

Dr. Peijian He investigates the regulation of iron metabolism and its role in metabolic disorders such as fatty liver disease and diabetes. His discovery of protein kinase C alpha as a novel regulator of intestinal iron absorption has advanced understanding of iron transport under both normal and pathological conditions. With publications in top-tier journals and multiple NIH grants, his work on hepatic iron toxicity is paving the way for new therapeutic targets in MASLD and related liver diseases.

Department of Neurology Lenora Higginbotham

Dr. Lenora Higginbotham is redefining our understanding of Lewy body dementia (LBD) by uncovering the biological complexity that current clinical definitions fail to capture. Using advanced systems-based proteomic techniques, her research identifies key protein heterogeneity in the LBD brain and translates these findings into accessible biomarkers in CSF and plasma. By developing biologically meaningful classifications, Dr. Higginbotham is paving the way for precision medicine approaches that can detect, monitor, and treat LBD and related dementias with greater accuracy and impact. Their work holds promise for transforming care across a spectrum of neurodegenerative diseases.

Read more about this researcher’s publications and impactful work.

Department of Pediatrics Samantha Hill

Dr. Samantha Hill is dedicated to improving HIV care for adolescents, with a focus on increasing access to Pre-Exposure Prophylaxis (PrEP). Her research advances health equity at both individual and systemic levels, often involving teens directly in the design of creative solutions. She is also a passionate mentor, with many publications co-authored with her mentees—a testament to her commitment to building inclusive pathways to career success in medicine and science.

Read more about this researcher’s publications and impactful work.

Department of Human Genetics Jian Hu

Dr. Jian Hu develops advanced statistical and machine learning methods for analyzing multi-modal omics data, including spatial transcriptomics, metabolomics, and digital pathology. His lab integrates single-cell and spatial data with clinical and histological information to uncover disease mechanisms and accelerate precision medicine. His computational frameworks are transforming how researchers interpret complex biological data, driving innovation in cancer, neuroscience, and beyond.

Read more about this researcher’s publications and impactful work.

Department of Radiology and Imaging Sciences Chuan Huang

Dr. Chuan Huang specializes in medical imaging technologies, including simultaneous PET/MRI and rapid MRI techniques. His development of a radial FSE method enables full-brain T2 mapping in under two minutes, enhancing diagnostic precision and efficiency. His work bridges advanced imaging with clinical applications, improving cancer diagnostics and treatment planning. He also contributes to procedural safety through the development of robotic systems for imaging-guided interventions.

Read more about this researcher’s publications and impactful work.

Department of Medicine Patricia Hwang

Dr. Patricia Hwang focuses on quality improvement in inpatient diabetes management. Her research includes developing protocols for diabetic ketoacidosis, especially in patients with comorbidities such as COVID-19 and end-stage renal disease. She works to reduce disparities, improve glycemic control, and promote safer, more equitable care both during hospitalization and at discharge. Her collaborations extend internationally, amplifying the reach and relevance of her work.

Department of Psychiatry and Behavioral Sciences Courtland Hyatt

Dr. Courtland Hyatt studies the causes and consequences of aggression, aiming to improve psychological treatments for this complex behavior. Using diverse methodologies—including neuroimaging and clinical interviews—he identifies risk factors such as personality traits and PTSD symptoms. His recent work highlights the treatment gap for aggressive behavior in military populations and the lack of clinician training, laying the groundwork for more effective and accessible interventions.

Department of Radiation Oncology Ashesh Jani

Dr. Ashesh Jani is the Vice Chair of Clinical Research and James C. Kennedy Professor in the Department of Radiation Oncology. He is a nationally respected physician-scientist specializing in genitourinary cancers. His research focuses on cancer outcome patterns and the use of advanced imaging technologies to refine treatment strategies. Through clinical trials, Dr. Jani has demonstrated that molecular imaging agents significantly improve the accuracy of detecting prostate cancer recurrence, and that integrating PET imaging into post-surgical treatment decisions enhances patient outcomes without increasing toxicity.

Read more about this researcher’s publications and impactful work.

Department of Pathology and Laboratory Medicine Seong Kang

Dr. Seong Kang is a translational neuroscientist whose research focuses on the pathological mechanisms driving neurodegenerative diseases. He investigates Tau pathology in Alzheimer’s disease, with particular attention to hormonal influences and inflammation along the gut-brain axis. His recent publication in Neuron revealed that an APOE variant can protect against Alzheimer’s by binding Tau and reducing its neuronal uptake—a discovery that opens new avenues for therapeutic intervention and deepens our understanding of disease progression.

Read more about this researcher’s publications and impactful work.

Department of Gynecology and Obstetrics Nadi Kaonga

Dr. Nadi Kaonga is advancing health systems strengthening through research that integrates technology into clinical workflows. As an academic generalist in OB/GYN and a member of the Cancer Prevention and Control Research Program, she explores how systems, policies, and care delivery intersect to improve outcomes for patients and providers. Her work spans global health contexts, from preventing mother-to-child HIV transmission to designing emergency response systems and digital health tools in low-resource settings. She is reshaping healthcare to be more equitable, efficient, and responsive.

Read more about this researcher’s publications and impactful work.

Department of Medicine Haritha Katakam

Dr. Haritha Katakam leads transformative efforts to improve patient transfers within Emory Healthcare. She developed a three-part Transfer Command Center model—triage physician integration, systemwide bed huddles, and load balancing—that significantly increased transfer efficiency and reduced delays. Her research has led to measurable improvements in patient flow, ensuring that individuals receive timely care in the right setting. Her work exemplifies operational excellence and data-driven innovation in healthcare systems.

Department of Gynecology and Obstetrics Elizabeth Kennedy

Dr. Liz Kennedy directs a molecular biology–driven research program focused on the placenta and breast milk—two vital mother–infant interfaces. Her studies reveal how placental molecular patterns influence fetal development and maternal health, and how microRNAs in breast milk shape infant growth and long-term outcomes. By decoding the molecular “dialogue” between mother and child, her work bridges fundamental science and clinical care, guiding interventions that promote healthier pregnancies and stronger developmental trajectories.

Read more about this researcher’s publications and impactful work.

Department of Pediatrics Alexandra 'Sasha' Key

Dr. Alexandra 'Sasha' Key investigates the neural mechanisms underlying autism and related developmental disorders. Her research explores brain differences in individuals with profound autism, including those who are nonverbal compared to those who are verbally fluent. Dr. Key’s work is helping to identify individualized intervention strategies and deepen our understanding of the neurobiology of autism, paving the way for more tailored and effective therapies.

Read more about this researcher’s publications and impactful work.

Department of Medicine Abhi Kole

Dr. Abhi Kole studies professional identity formation among MD/PhD students, exploring how dual-degree trainees define themselves as physician-scientists across diverse career paths. His research examines factors such as training sequence, mentor influence, and peer communities to understand what binds this group together. By identifying key facilitators of identity formation, his work aims to foster belonging and reduce attrition in the physician-scientist workforce.

Read more about this researcher’s publications and impactful work.

Department of Radiology and Imaging Sciences Lisa Krishnamurthy

Dr. Lisa Krishnamurthy is a translational MR physicist specializing in MRI sequence design for rehabilitation science. Her research applies advanced imaging to study stroke-related changes in neurotransmitters, perfusion, and metabolism, guiding personalized recovery strategies. Working directly with veterans, she improves rehabilitation outcomes and quality of life. Her TRU-PC MRI method has earned international recognition for its innovation and clinical relevance.

Read more about this researcher’s publications and impactful work.

Department of Psychiatry and Behavioral Sciences Benson Ku

Dr. Benson Ku investigates environmental risk factors contributing to psychosis in youth by linking individual data with geographic markers of social stress. His research incorporates genetic biomarkers to explore gene-by-environment interactions in neurodevelopment. This approach enables tailored early interventions and holds promise for reducing the burden of psychotic disorders in vulnerable populations.

Read more about this researcher’s publications and impactful work.

Department of Pediatrics Jocelyn Kuhn

Dr. Jocelyn Kuhn promotes accessible, evidence-based mental and behavioral health care for children and adolescents on the autism spectrum. Her research targets key transitions across the lifespan, including early diagnosis and the shift to adulthood. By developing strategies that empower pediatricians and primary care providers to diagnose autism, she is accelerating access to care for families who face barriers to specialty services.

Read more about this researcher’s publications and impactful work.

Department of Medicine Frances Eun-Hyung Lee

Dr. Frances Eun-Hyung Lee investigates the biology of long-lived plasma cells (LLPCs) and their role in immunity. Her lab has pioneered diagnostic platforms based on plasmablasts and revealed critical insights into vaccine-induced LLPC responses. Her work informs the design of next-generation vaccines aimed at achieving durable immunity.

Read more about this researcher’s publications and impactful work.

Department of Radiation Oncology Liyong Lin

Dr. Liyong Lin develops Monte Carlo–based platforms for proton dose and microdosimetric calculations, advancing precision in proton therapy. His work supports open collaboration and independent validation, enhancing clinical trials and care quality. By integrating deep learning and exploring radiation immune biomarkers, his research pushes the boundaries of radiation oncology. His recently awarded R03 grant will expand access to microdosimetry tools across institutions.

Read more about this researcher’s publications and impactful work.

Department of Pediatrics Latania Logan

Dr. Latania Logan studies antimicrobial resistance in Gram-negative bacterial pathogens, focusing on environmental contributors such as agriculture, animals, and wastewater. Her research reveals how resistance can develop in children without direct antimicrobial exposure, highlighting community reservoirs as key risk factors. By combining clinical and molecular epidemiology, she informs treatment strategies and improves care for pediatric infections.

Read more about this researcher’s publications and impactful work.

Department of Medicine Meredith Lora

Dr. Meredith Lora leads research in HIV prevention and implementation science, directing Grady’s comprehensive PrEP program. She evaluates patient-centered delivery models, including one of the nation’s first Cabotegravir Long-Acting Injectable PrEP programs. Her work has trained over 300 staff and initiated PrEP for more than 500 patients, with adherence rates far exceeding local benchmarks. Her research guides replication of successful models in other health systems.

Department of Family and Preventive Medicine Jane Lowers

Dr. Jane Lowers conducts groundbreaking research on aging populations who navigate later life without traditional support networks. Her work challenges assumptions about family-based caregiving and highlights the needs of individuals aging solo. By focusing on this under-recognized group, she is shaping more inclusive approaches to palliative care, geriatrics, and dementia support.

Read more about this researcher’s publications and impactful work.

Department of Pediatrics Mark Mai

Dr. Mark Mai integrates predictive analytics and machine learning into pediatric acute and critical care to improve outcomes for critically ill children. His research develops decision-support tools and technology-enhanced systems that optimize care delivery and support clinical teams. By embedding data-driven approaches into workflows, he enhances safety and enables timely, evidence-based decisions in neonatal and pediatric intensive care settings.

Department of Gynecology and Obstetrics Beryl Manning-Geist

Dr. Beryl Manning-Geist is an Assistant Professor and clinical investigator in Gynecologic Oncology whose research centers on discovery and developmental therapeutics for endometrial, ovarian, and cervical cancers. She leads multiple clinical trials, including an investigator-initiated study on low-grade serous ovarian carcinoma and trials exploring antibody-drug conjugates and PARP inhibitor optimization. Recognized by leading institutions such as the Society of Gynecologic Oncology and Memorial Sloan Kettering, Dr. Manning-Geist is shaping the future of gynecologic cancer care through precision therapeutics and surgical innovation.

Department of Psychiatry and Behavioral Sciences Jess Maples-Keller

Dr. Jess Maples-Keller is pioneering new models of PTSD treatment through translational science and clinical trials. Her work integrates virtual reality exposure therapy, transcranial magnetic stimulation, and psychedelic-assisted therapies. She has led randomized trials in underserved populations and cancer survivors, and currently serves as PI on Department of Defense grants evaluating MDMA for PTSD. Her research explores how estradiol and MDMA influence fear extinction and therapy outcomes, advancing the field of exposure-based psychotherapy and psychedelic medicine.

Department of Medicine Vincent Marconi

Dr. Vincent Marconi investigates biological, social, and behavioral determinants of the HIV treatment response. His work informs interventional trials aimed at improving quality of life for people living with HIV, while also exploring inflammation’s role in aging and HIV eradication. Dr. Marconi’s research bridges global health and precision medicine to improve adherence and retention in antiretroviral therapy.

Read more about this researcher’s publications and impactful work.

Department of Surgery Nader Massarweh

Dr. Nader N. Massarweh, Associate Professor of Surgical Oncology and Vice Chair for Veterans Affairs, leads research in surgical outcomes, health services, and quality improvement. He evaluates national policy impacts and surgical quality metrics using large-scale data and implementation science. His work ensures that performance benchmarks reflect real-world outcomes and drive sustainable improvements in care—especially for veterans.

Read more about this researcher’s publications and impactful work.

Department of Human Genetics Zachary T. McEachin

Dr. Zachary McEachin investigates the molecular drivers of neurodegeneration in amyotrophic lateral sclerosis and frontotemporal dementia, focusing on cell-type–specific vulnerability. His integrative multiomic approach reveals disease-specific molecular changes, enabling biomarker development and targeted therapies. Dr. McEachin’s work is redefining the biological landscape of neurodegenerative disease.

Department of Pediatrics Vineet Menachery

Dr. Vineet Menachery leads a cutting-edge virology lab that explores host-virus interactions using coronaviruses as a model. His team develops tools to probe immune system function and viral pathogenesis, offering insights into coronavirus emergence and disease outcomes. Dr. Menachery’s research informs pandemic preparedness and therapeutic development.

Department of Psychiatry and Behavioral Sciences Vas Michopoulos

Dr. Vas Michopoulos is a nationally recognized expert in women’s mental health, behavioral neuroendocrinology, and psychoimmunology. Her translational research spans rhesus monkey stress models and human studies in chronically stressed minority populations. Dr. Michopoulos’s work advances understanding of stress-related health disparities and drives innovation in women’s health.

Read more about this researcher’s publications and impactful work.

Department of Radiation Oncology Kyle Miller

Dr. Kyle Miller, Professor of Radiation Oncology, investigates genome maintenance, chromatin biology, and DNA damage responses. His research reveals how transcription, replication, and repair processes interact to preserve genome integrity and how their dysregulation contributes to cancer. With landmark publications in Molecular Cell and Nature, Dr. Miller is a thought leader in cancer biology, uncovering new therapeutic targets and strategies at the genome and epigenome levels.

Read more about this researcher’s publications and impactful work.

Department of Neurology Svjetlana Miocinovic

Dr. Svjetlana Miocinovic conducts patient-centered research in deep brain stimulation (DBS) for movement disorders such as Parkinson’s disease and dystonia. Her innovative use of intraoperative electrophysiology recordings allows her to measure cortically evoked potentials during DBS lead placement, revealing connectivity between the subthalamic nucleus and cortical regions. Through imaging-based studies, she is refining patient-specific DBS models to optimize motor outcomes and deepen our understanding of DBS-related brain circuitry.

Read more about this researcher’s publications and impactful work.

Department of Medicine Alberto Moreno

Dr. Alberto Moreno began his career in malaria vaccine development and has recently shifted focus to acquired immunity against emerging infections like influenza and coronaviruses. He played a key role in developing COVID-19 endpoint assays and continues to lead projects on influenza vaccine characterization. His recent publication in Lancet Infectious Diseases demonstrated cross-variant protection from existing COVID-19 vaccines, a critical advancement in respiratory virus immunology.

Read more about this researcher’s publications and impactful work.

Department of Pediatrics Claudia Morris

Dr. Claudia Morris is internationally recognized for her translational research on sickle cell disease, particularly in addressing vaso-occlusive pain crises. Her groundbreaking work on arginine as a non-opioid adjunct therapy has reshaped treatment paradigms. As nodal PI for the Pediatric Emergency Care Applied Research Network (PECARN), she has built a nationally recognized pediatric emergency medicine research infrastructure. She also holds a prestigious NIH K24 mentoring award and is celebrated for her dedication to advancing the careers of her mentees.

Read more about this researcher’s publications and impactful work.

Department of Microbiology and Immunology Chris Neufeldt

Dr. Chris Neufeldt investigates how positive-strand RNA viruses, including Zika and coronaviruses, manipulate cellular membranes to support replication and evade immune detection. His research combines advanced microscopy, genetic screening, and molecular biology to uncover how protein trafficking and ER remodeling facilitate viral survival. These insights are driving the identification of novel antiviral targets.

Department of Gynecology and Obstetrics Anna Newton-Levinson

Dr. Anna Newton-Levinson is an applied researcher working at the intersection of gynecology, public health, and social equity. She uses community-engaged, mixed-methods, and implementation science approaches to address sexual and reproductive health access—particularly in the Southeast. Her studies on contraception, postpartum care, and abortion highlight how policy, infrastructure, and social determinants shape health outcomes. Her work has informed legislative testimony and continues to drive actionable solutions for reproductive health.

Read more about this researcher’s publications and impactful work.

Department of Dermatology Lauren Orenstein

Dr. Lauren Orenstein is a nationally recognized clinician scientist whose research focuses on the mechanisms and management of severe pain in hidradenitis suppurativa. Her interdisciplinary collaborations with pain management and burn surgery teams have led to the development of treatment algorithms for this debilitating condition. A recipient of the Emory at Grady Research Infrastructure Support Award, Dr. Orenstein continues to inspire colleagues and improve care for patients with complex dermatologic pain.

Read more about this researcher’s publications and impactful work.

Department of Rehabilitation Medicine Sonal Oza

Dr. Sonal Oza is leading a nationwide multi-center trial to evaluate botulinum toxin for pain and spasm relief following radiation in head and neck cancer. Despite its clinical promise, botulinum toxin remains understudied and often denied by insurers due to limited evidence. This trial aims to generate the data needed to support broader access and improve quality of life for thousands of patients.

Read more about this researcher’s publications and impactful work.

Department of Cell Biology Devesh Pant

Dr. Devesh Pant is a rising star in the Department of Cell Biology, known for his rigorous and collaborative approach to studying rare genetic neurological disorders. His work using novel techniques has uncovered actionable disease pathways in Spinal Muscular Atrophy and expanded the genotype-phenotype understanding of SPTLC1 and KIF5A disorders. Dr. Pant’s commitment to both scientific excellence and patient engagement is driving progress in diagnosis and treatment.

Read more about this researcher’s publications and impactful work.

Department of Neurology Stella Papa

Dr. Stella Papa focuses on experimental therapeutics for Parkinson’s disease and movement disorders. Her research on striatal dysfunction due to chronic dopamine loss has revealed critical insights into neural circuitry. Using gene transfer strategies and high-resolution cellular analysis, Dr. Papa is developing novel gene therapies with the potential to modify disease progression and improve clinical outcomes for Parkinson's Disease patients.

Read more about this researcher’s publications and impactful work.

Department of Hematology and Medical Oncology Ravi Parikh

Dr. Ravi Parikh is advancing end-of-life care for Veterans through a large VA-funded study that combines lay health worker interventions with algorithm-driven patient identification. Building on the Life-Sustaining Treatment Decisions Initiative, his work addresses the gap in Goals of Care communication among Veterans with cancer. The study spans seven VA oncology sites and aims to improve documentation, reduce anxiety and depression, and inform scalable, Veteran-centric care models.

Read more about this researcher’s publications and impactful work.

Department of Medicine Jeanie Park

Dr. Jeanie Park’s research explores autonomic dysfunction and cardiovascular risk in patients with chronic kidney disease, hypertension, and PTSD. Her lab investigates sympathetic nervous system regulation using human physiology models, with funding from the NIH, VA, DoD, and foundations. Dr. Park’s translational work is improving clinical outcomes for high-risk populations, including Veterans and individuals with stress-related disorders.

Read more about this researcher’s publications and impactful work.

Department of Orthopaedics Josh Parry

Dr. Josh Parry is a leading clinical investigator in musculoskeletal trauma and fracture care. His research addresses everyday dilemmas in orthopedic practice, with a focus on bony pelvic ring injuries that challenge clinicians and patients alike. Dr. Parry’s practical studies and mentorship are shaping the future of orthopedic care at Grady and beyond, while building infrastructure to support ongoing innovation.

Read more about this researcher’s publications and impactful work.

Department of Pediatrics Dharmeshkumar Patel

Dr. Dharmeshkumar Patel is an expert in computational drug discovery, applying advanced software tools to accelerate the identification and testing of candidate therapeutics. His work spans molecular docking, toxicity modeling, and in silico screening for diseases including emerging viral threats. Dr. Patel’s collaborations are helping research teams move promising compounds toward clinical validation with speed and precision.

Read more about this researcher’s publications and impactful work.

Department of Pediatrics Michelle-Marie Pena

Dr. Michelle-Marie Peña is a neonatologist whose research centers on improving outcomes for high-risk mother-infant dyads in the neonatal intensive care unit. Her work promotes parent milk provision and skin-to-skin care, and she leads implementation science studies addressing social drivers of health. As a K12 BIRCWH scholar and NIH-funded investigator, Dr. Peña is setting national standards for focused neonatal care.

Department of Medicine Lawrence Phillips

Dr. Lawrence Phillips conducts wide-ranging research in diabetes pathophysiology, clinical inertia, and healthcare delivery. His work has shown that overcoming clinical inertia improves metabolic control, and he has developed strategies to enhance diabetes management in primary care. Now focused on early detection of prediabetes, Dr. Phillips is advancing cost-effective screening tools that enable preventive care at the earliest stages of glucose intolerance.

Department of Radiology and Imaging Sciences Amir Pourmorteza

Dr. Amir Pourmorteza is a leader in spectral and high-resolution computed tomography (CT), cardiac imaging, and AI applications. He conducted the first clinical studies of photon-counting CT, improving tissue characterization and reducing radiation. His development of SQUEEZ enables high-resolution 3D myocardial strain analysis. Through radiogenomics, Dr. Pourmorteza is advancing personalized cancer therapy and enhancing cardiovascular diagnostics.

Read more about this researcher’s publications and impactful work.

Department of Pediatrics CK Qu

Dr. CK Qu leads groundbreaking research on hematopoietic stem cells and leukemia-initiating cells. His studies have significantly advanced understanding of Noonan Syndrome and childhood leukemia, with publications in top-tier journals like Nature, Cell Stem Cell, and PNAS. Funded by multiple NIH grants, Dr. Qu’s work reveals novel disease mechanisms and informs clinical strategies for pediatric hematologic malignancies.

Read more about this researcher’s publications and impactful work.

Department of Dermatology Cassandra Quave

Dr. Cassandra Quave is an internationally recognized ethnobotanist and tenured professor whose research bvridges natural products and dermatology. As Curator of the Emory Herbarium she discovers novel bioactive compounds with antibiotic properties. Her interdisciplinary work earned her recognition as a CNN Champion for Change in 2024, highlighting her global impact on medicine and biodiversity.

Read more about this researcher’s publications and impactful work.

Department of Hematology and Medical Oncology Sarwish Rafiq

Dr. Sarwish Rafiq is advancing cellular therapies by enhancing the efficacy and safety of CAR T cells and other “living drugs.” Her research develops sophisticated strategies to overcome resistance in cancer and autoimmune diseases, pushing the boundaries of immunotherapy and personalized medicine.

Read more about this researcher’s publications and impactful work.

Department of Radiology and Imaging Sciences Sundaresh Ram

Dr. Sundaresh Ram leads research in computational imaging and AI, developing quantitative biomarkers for personalized medicine. His work spans MRI, CT, SPECT, and microscopy, with innovations in image restoration, segmentation, and motion analysis. Dr. Ram’s interpretable AI pipelines improve lesion detection and reduce variability in pathology workflows, streamlining diagnosis and treatment across diseases like cancer and cystic fibrosis.

Read more about this researcher’s publications and impactful work.

Department of Emergency Medicine Jonathan Ratcliff

Dr. Jonathan Ratcliff leads clinical trials focused on improving care for patients with neurologic emergencies such as traumatic brain injury, stroke, and status epilepticus. His research has demonstrated the efficacy of new treatments that are transforming acute neurologic care and improving patient outcomes.

Department of Psychiatry and Behavioral Sciences Sheila Rauch

Dr. Sheila Rauch is a leading expert in PTSD research and treatment. She serves as Principal Investigator on multiple trials, including a DOD-funded study comparing prolonged exposure therapy and sertraline, and a VA/DOD trial examining biomarkers in military populations. Her work spans neurobiology, anxiety disorders, and adaptation of psychotherapeutic interventions across diverse clinical settings, with a focus on improving access and outcomes.

Read more about this researcher’s publications and impactful work.

Department of Pediatrics Chris Rees

Dr. Chris Rees is a rising leader in global pediatric emergency medicine. He directs a 9-country working group within the CHAMPS network and was recently appointed Director of the Global Health Office of Pediatrics at Emory. His research identifies children at risk for mortality in low-resource settings and develops strategies to reduce preventable deaths. With over 100 publications and a K23 grant, Dr. Rees is shaping global child health policy and practice.

Read more about this researcher’s publications and impactful work.

Department of Radiation Oncology Jill Remick

Dr. Jill Remick treats patients with gynecologic and head and neck cancers, and her research centers on personalizing radiation therapy to improve clinical outcomes and reduce treatment-related side effects. She leads clinical trials that evaluate innovative radiation techniques, with a strong emphasis on patient-reported outcomes and quality of life. Dr. Remick’s work ensures that advances in technology are translated into more tolerable and effective therapies, improving survivorship through individualized treatment planning.

Read more about this researcher’s publications and impactful work.

Department of Biomedical Informatics Matt Reyna

Dr. Matthew Reyna develops algorithmic approaches to solve clinical and biological problems using large biomedical datasets. His research spans computational cancer genomics and machine learning for unsolved clinical challenges. Through leadership in the NIH-funded PhysioNet Challenges, Dr. Reyna fosters a global community focused on reproducible, open-source tools that improve medical AI and patient care.

Read more about this researcher’s publications and impactful work.

Department of Pathology and Laboratory Medicine Susan P. Ribeiro

Dr. Susan Ribeiro investigates HIV reservoir persistence and strategies for cure using multiomic approaches. Her research explores immune dysregulation in tissues such as the gut and lymph nodes, and the impact of comorbidities and substance use. She is PI on four NIH grants and leads international collaborations, including the Buriti Network for Down Syndrome research in Brazil. Her work has led to unprecedented viral control in macaque models and inspired new therapeutic studies.

Read more about this researcher’s publications and impactful work.

Department of Surgery Seth Rosen

Dr. Seth Rosen leads a pioneering research program in robotic colorectal surgery. His work develops objective performance metrics to evaluate surgical platforms, outcomes, and training methods. Collaborating across disciplines—including with Georgia Tech—Dr. Rosen’s methodology is advancing the field and improving surgical education and patient care.

Read more about this researcher’s publications and impactful work.

Department of Emergency Medicine Marta Rowh

Dr. Marta Rowh specializes in enhancing the quality and accuracy of medical education materials through advanced technologies. She leverages machine learning and natural language processing to analyze educational content efficiently and has received multiple grants to support her innovative research. Her work is transforming how medical curricula are evaluated and refined to ensure clarity, relevance, and effectiveness.

Read more about this researcher’s publications and impactful work.

Department of Psychiatry and Behavioral Sciences Mar Sanchez

Dr. Mar Sanchez uses translational models in nonhuman primates to investigate how early life stress (ELS) affects physiological, molecular, and emotional development. Her research has shown that disruptions in maternal care and chronic psychosocial stress increase vulnerability to mood and anxiety disorders. Recently, she has focused on how ELS contributes to substance use disorders, uncovering neurobiological mechanisms that heighten addiction risk. Dr. Sanchez is internationally recognized for her contributions to developmental neuroscience and psychopathology.

Read more about this researcher’s publications and impactful work.

Department of Biomedical Engineering Philip Santangelo

Dr. Philip Santangelo leads groundbreaking research in mRNA-based therapeutics, particularly for emerging viral diseases like H5N1. His collaborative work includes novel delivery methods in large animal models, such as intramammary administration in cows, to study disease transmission and progression. By integrating cellular-level insights with therapeutic innovation, Dr. Santangelo is expanding our understanding of viral infection and advancing the next generation of targeted treatments.

Read more about this researcher’s publications and impactful work.

Department of Medicine Erin Scherer

Dr. Erin Scherer investigates the immune mechanisms behind the durable antibody responses of the HPV vaccine. Her research uses animal models and clinical trials to study B cell memory and immune site sampling in lymph nodes and bone marrow. Dr. Scherer’s work informs vaccine design and public health policy, including evaluating whether reduced-dose regimens maintain effective immune responses.

Read more about this researcher’s publications and impactful work.

Department of Family and Preventive Medicine Megha Shah

Dr. Megha Shah advances chronic disease prevention through community-partnered interventions. Her work uses lay health educators and peer support models to improve diabetes and hypertension outcomes in under-resourced populations. By linking clinics with communities, Dr. Shah’s research demonstrates scalable, culturally tailored strategies to improve health.

Department of Psychiatry and Behavioral Sciences Andrew Sherrill

Dr. Andrew Sherrill integrates virtual reality, artificial intelligence, and mobile health into exposure therapy for trauma and anxiety disorders. His research develops scalable tools that enhance clinician training and patient engagement, with a focus on military and veteran populations. By bridging psychological science and human-computer interaction, Dr. Sherrill creates innovative systems that expand access to high-quality mental health care and empower both clinicians and patients.

Read more about this researcher’s publications and impactful work.

Department of Medicine Shanthi Srinivasan

Dr. Shanthi Srinivasan’s research explores the survival and differentiation of the Enteric Nervous System (ENS), a vital network of neurons and glia in the gut. Her lab uses primary cultures of rat embryonic enteric neurons to study how Ret receptor signaling and its ligand GDNF influence neuronal development. Through microarray analysis, her team has identified genes regulated by GDNF, offering new insights into enteric neuron survival and proliferation. She is also investigating how diabetes impacts ENS function and gastrointestinal motility.

Read more about this researcher’s publications and impactful work.

Department of Radiology and Imaging Sciences Phil Sun

Dr. Phil Sun develops novel MRI methodologies and translates them into clinical applications. He has played a key role in advancing chemical exchange saturation transfer (CEST) and diffusion kurtosis imaging (DKI), applying these techniques to conditions such as stroke, tumors, epilepsy, and kidney disease. His current research focuses on quantitative CEST (QCEST) and its use in Parkinson’s disease, conducting test-retest scans to evaluate its clinical utility. Dr. Sun’s work is creating new imaging biomarkers that illuminate disease progression and support the development of targeted treatments for neurological and systemic disorders.

Read more about this researcher’s publications and impactful work.

Department of Neurology Eleanor Thomas

Dr. Eleanor Thomas is a clinician-scientist advancing ALS research through the study of neuroinflammation. She is developing blood-based bioassays to detect inflammatory patterns in ALS patients and asymptomatic gene carriers. Her work is transforming diagnostic and therapeutic approaches, bringing the field closer to early detection and targeted treatment of ALS.

Read more about this researcher’s publications and impactful work.

Department of Psychiatry and Behavioral Sciences Sanne van Rooij

Dr. Sanne van Rooij leads a research program on biobehavioral mechanisms of resilience and recovery from traumatic stress. As founder of the Stress and Neuromodulation Lab, she develops personalized neurotherapeutics and has identified focal brain stimulation targets for PTSD using neuroimaging. Her work advances trauma recovery science and contributes to innovative treatment development.

Read more about this researcher’s publications and impactful work.

Department of Pathology and Laboratory Medicine Vijayakumar Velu

Dr. Vijayakumar Velu’s research focuses on enhancing the immune system’s ability to recognize and eliminate infected or cancerous cells. His work has identified key mechanisms of T cell and NK cell dysfunction and developed interventions to improve their function and migration to sites of viral or tumor persistence. His clinically relevant discoveries contribute to advancing immunotherapy and infectious disease treatment.

Read more about this researcher’s publications and impactful work.

Department of Medicine Susan Wall

Dr. Susan Wall’s laboratory investigates the apical Cl⁻/HCO₃⁻ exchanger, pendrin, in type B intercalated cells, revealing its role in K⁺-sparing NaCl absorption. Her studies in pendrin knockout mice have shown how pendrin deficiency affects electrolyte balance, blood pressure, and compensatory mechanisms like ENaC downregulation. With over three decades of NIH funding, Dr. Wall’s work has significantly shaped our understanding of renal physiology and blood pressure regulation.

Department of Pediatrics Chia-shi Wang

Dr. Chia-shi Wang is a national leader in childhood kidney disease, with a focus on glomerular disease and nephrotic syndrome. Her research helps families make informed treatment decisions, explores long-term outcomes, and tests novel therapies through clinical trials. Dr. Wang’s work improves patient engagement and adherence, ultimately enhancing care for children with chronic kidney conditions.

Department of Pathology and Laboratory Medicine Qun Wang

Dr. Qun Wang advances cervical cancer prevention through large-scale analysis of HPV infection, cotesting, and genotyping within the Emory healthcare system. Her research informs risk-based screening guidelines and identifies high-risk HPV subtypes linked to HSILs. By bridging lab science with clinical practice, Dr. Wang’s work improves early detection and personalized patient management across diverse populations.

Department of Psychiatry and Behavioral Sciences Zhexing Wen

Dr. Zhexing Wen studies brain function using cutting-edge models like induced pluripotent stem cells and organoids. His research spans Fragile X syndrome, Alzheimer’s disease, and schizophrenia, uncovering molecular mechanisms of neuropsychiatric disorders. Notably, he identified a DISC1 mutation causing synaptic deficits in human neurons. Dr. Wen is a leading figure in modeling brain disease and a dedicated mentor to emerging scientists.

Read more about this researcher’s publications and impactful work.

Department of Medicine TaRessa Wills

Dr. TaRessa Wills researches health and operational practice in hospital medicine. Her work addresses bias in clinical narratives, explores success among underrepresented hospitalists, and examines the impact of hospital closures. Through scholarship and mentorship, she advocates for education and systems-level change in academic medicine.

Read more about this researcher’s publications and impactful work.

Department of Anesthesiology Anna Woodbury

Dr. Anna Woodbury’s clinical expertise and research focus on interventional, neuromodulatory, and complementary therapies for non-narcotic pain management. Her work aims to uncover the neural mechanisms of chronic pain and develop innovative treatments that reduce risk while improving function and quality of life. Dr. Woodburry’s science is making a meaningful impact on communities through integrative medicine and neuromodulation, with applications in chronic pain, anesthesia, and neuroprotection.

Read more about this researcher’s publications and impactful work.

Department of Surgery Lily Yang

Dr. Lily Yang directs Emory’s Surgical Oncology Nanomedicine Research Lab and holds the Nancy Panoz Chair of Surgery in Cancer Research. She designs theranostic nanoparticles that combine imaging and therapy for early detection and targeted treatment of drug-resistant cancers. Her research integrates immune modulation and stroma-penetrating delivery to overcome therapeutic barriers and personalize oncology care. Dr. Yang’s NIH-funded work is transforming cancer treatment by improving precision, reducing toxicity, and enhancing patient outcomes.

Department of Radiation Oncology Xiaofeng Yang

Dr. Xiaofeng Yang’s research centers on artificial intelligence and advanced imaging in radiation oncology. He develops AI-based tools for image segmentation, deformable registration, and synthetic CT generation to improve radiotherapy accuracy and efficiency. Through multi-institutional collaborations and public datasets, Dr. Yang accelerates clinical translation of AI innovations, addressing longstanding challenges in adaptive therapy and expanding access to high-quality cancer care.

Read more about this researcher’s publications and impactful work.

Department of Dermatology Howa Yeung

Dr. Howa Yeung is a nationally recognized clinical researcher in dermatology. His work has advanced understanding of skin cancer epidemiology in men who have sex with men and the dermatologic effects of hormone therapy. Dr. Yeung is also a dedicated mentor, leading research initiatives and journal clubs that inspire the next generation of dermatologists.

Department of Pediatrics Brian Zanoni

Dr. Brian Zanoni leads a research team dedicated to improving care engagement for adolescents living with HIV. His work focuses on supporting youth from adolescence into adulthood, helping them manage their health and remain connected to care. Through strong partnerships with academic centers in South Africa, Dr. Zanoni’s team designs interventions using technology and implementation science to optimize retention and self-management in vulnerable populations.

Read more about this researcher’s publications and impactful work.

Department of Pathology and Laboratory Medicine Patricia Zerra

Dr. Patricia Zerra’s research addresses blood bank challenges related to coagulation and sickle cell disease. She investigates immune responses to red blood cell transfusions in sickle cell patients and to factor VIII in hemophilia, supported by NIH and foundation grants. As a pediatric hematologist and blood banking specialist, Dr. Zerra transforms patient-centered questions into impactful research, advancing care for children with complex hematologic conditions.

Read more about this researcher’s publications and impactful work.